This article is more than 5 years old. Information may no longer be current.
ID News prepares for IDWeek 2017
Click Here to Manage Email Alerts
SAN DIEGO — Infectious Disease News and Healio.com will be onsite at IDWeek 2017 to provide live coverage of the latest research presented at the conference, held from Oct. 4 to 8.
IDWeek is the joint scientific meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, and the Pediatric Infectious Diseases Society. The annual meeting brings together thousands of researchers, clinicians, quality and patient safety practitioners, epidemiologists and public health officials to share the latest developments in the field.
At the meeting, IDN staff will offer news presented at the meeting, as well as video interviews with experts in the field to get their perspectives on important presentations. Readers can also expect newswires featuring the conference’s top headlines. Visit our IDWeek meeting page throughout the week to keep up with the latest news.
Before IDWeek 2017 begins, check out some of the top stories from last year’s conference:
Antibiotic-resistant pathogens often found on nurses’ scrubs
NEW ORLEANS — Findings from the ASCOT trial showed that antibiotic-resistant pathogens were frequently transmitted from patients in the ICU and their environments to nurses’ clothing.
Project CLEAR: Serial decolonization reduces MRSA infection after hospital discharge
NEW ORLEANS — Results from a randomized controlled trial showed that decolonization with mupirocin and chlorhexidine reduced both MRSA and all-cause infection over a 1-year period in MRSA carriers who were recently discharged from a hospital. Read more.
Fatal measles complication more common than previously understood
NEW ORLEANS — James D. Cherry, MD, MSc, reported that subacute sclerosing panencephalitis — a 100% fatal complication of measles — occurs much more often than previously thought. In a subanalysis of children who developed measles in the United States, the incidence of SSPE was one in 1,387 among those infected before age 5 years, and one in 609 among those infected before age 12 months. Read more.
Long-acting monoclonal antibody successful as rescue therapy for MDR HIV
NEW ORLEANS — TaiMed Biologics’ investigational monoclonal antibody ibalizumab led to significant reductions in viral load in patients with multidrug-resistant HIV when it was added to a failing drug regimen, according to results from a phase 3 trial. Researchers also said the drug, given intravenously once every 2 weeks, was safe and well-tolerated. Read more.
Researchers define ‘skip phenomenon’ in patients with S. aureus bacteremia
NEW ORLEANS — For older men treated for Staphylococcus aureus bacteremia who have received immunosuppressive agents, a single negative blood culture may be insufficient to demonstrate clearance. Read more.
To read more from IDWeek 2016, click here.